Numbness in the feet is a symptom of neuropathy or nerve damage, one of the most common long-term complications of type 2 ...

With our current indications, adults with painful diabetic peripheral neuropathy of the feet and postherpetic neuralgia, we ...

Qutenza (capsaicin) may be prescribed for adults to treat neuropathic pain associated with postherpetic neuralgia and for neuropathic pain associated with diabetic peripheral neuropathy. Learn ...

How to contact Medicare for questions about Qutenza coverage. For questions about Qutenza or other pain management coverage, call Medicare at 800-MEDICARE (800-633-4227). TTY users can call 877 ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Diabetic neuropathy—the most common neuropathy in industrialized countries—encompasses a broad range of clinical manifestations. In this Review, Gérard Said discusses the clinical ...

News. UTD scientists solve 100-year-old mystery behind diabetic nerve damage Nageotte nodules, once overlooked, may hold the key to understanding and treating diabetic peripheral neuropathy.

AACHEN, Germany and MORRISTOWN, N.J., Nov. 7, 2024 /PRNewswire/ -- Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical ...

Original Medicare Part B may cover Qutenza (capsaicin) if your doctor prescribes the medication for FDA-approved purposes and the pharmacy you use accepts Medicare. Learn more.